Literature DB >> 5494361

The effect of oxprenolol on cardiac intracellular potentials in relation to its anti-arrhythmic, local anaesthetic and other properties.

E M Vaughan Williams, J G Papp.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5494361

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  9 in total

1.  Influence of lipid solubility on the sperm immobilizing effect of beta-adrenoceptor blocking drugs.

Authors:  C Y Hong; P Turner
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

2.  Propranolol and thyroid hormones.

Authors:  M K Jones; G R Jones; J Birtwell
Journal:  Br Med J       Date:  1980-08-09

Review 3.  Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.

Authors:  D G Gibson
Journal:  Drugs       Date:  1974       Impact factor: 9.546

Review 4.  Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.

Authors:  B N Singh; D E Jewitt
Journal:  Drugs       Date:  1974       Impact factor: 9.546

5.  Effects of propranolol and oxprenolol on the vasoconstrictor response to noradrenaline in the superficial hand vein in man.

Authors:  J O'Grady; V Oh; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1978-11-16       Impact factor: 2.953

6.  Evaluation of oxprenolol slow release and osmotic release by exercise testing and ambulatory electrocardiographic monitoring in patients with chronic stable angina pectoris.

Authors:  M J Bowles; N S Khurmi; M J O'Hara; E B Raftery
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  The actions of a new beta-adrenoceptor blocking drug, ICI 66082, on the rabbit papillary muscle and on the dog heart.

Authors:  J D Harry; M F Knapp; R J Linden
Journal:  Br J Pharmacol       Date:  1974-06       Impact factor: 8.739

8.  Further studies regarding the structure activity relationships of beta-adrenoceptor antagonists.

Authors:  E E Bagwell; E M Williams
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

9.  Cardiovascular effects of bevantolol, a selective beta 1-adrenoceptor antagonist with a novel pharmacological profile.

Authors:  I D Dukes; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.